Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad558 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Mattia Trunfio und 11 weiteren Autor:innen. Beteiligte Einrichtung: HIV Neurobehavioral Research Program, Departments of Neurosciences and Psychiatry, University of California San Diego,San Diego, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Biomarkers, Selective Serotonin Reuptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIMH NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Persistent inflammation affects people with HIV (PWH) despite antiretroviral therapy (ART). Selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs, SNRIs), HMG-CoA reductase-inhibitors (statins), and angiotensin-converting enzyme inhibitors (ACEIs) have immunomodulant properties. We evaluated the potential impact of these drugs on inflammation and neurodegeneration in PWH.
Methods
Cross-sectional single-center (United States) analysis in 184 PWH on ART with plasma HIV RNA < 200 copies/mL. All participants had 10 biomarkers measured in blood and cerebrospinal fluid (CSF). To reduce dimensionality, hierarchical clustering and principal components (PCs) analysis were employed. The analyses were adjusted for duration of the drugs and clinical conditions.
Results
Participants were mostly middle-aged men, with median CD4+ T cells of 620/µL. In adjusted models, SSRI use was associated with 3 PCs: higher CSF and plasma Aβ42 and CSF CCL2 (aβ=.14, P = .040); lower CSF 8-oxo-dG, total tau, and sCD14 (aβ=−.12, P = .042); and higher plasma sCD14 with lower sCD40L (aβ=.15, P = .042). SNRI use was associated with higher values of CSF and plasma neopterin and CSF sTNFR-II (aβ=.22, P = .004). Statins and ACEIs showed no association.
Conclusions
SSRIs and SNRIs had distinct biomarker signatures. SSRIs were associated with reduced neurodegeneration, immune activation, and oxidative stress in CSF, suggesting a role of SSRIs as adjunctive therapy in PWH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HIV Neurobehavioral Research Program, Departments of Neurosciences and Psychiatry, University of California San Diego,San Diego, California, USA.
- Department of Medical Sciences, University of Turin, Turin, Italy.
- Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of Buffalo, Buffalo, New York, USA.
ORCID-Profile: Mattia Trunfio, Qing Ma
Förderung
- NIDA NIH HHS
- NIMH NIH HHS
- NIH HHS
- NIA NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Trunfio, M., Tang, B., Iudicello, J. E., Ma, Q., Franklin, D. R., Cookson, D., Riggs, P. K., Cherner, M., Moore, D. J., Heaton, R. K., Letendre, S. L., & Ellis, R. J. (2024). Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad558
Vancouver
Trunfio M, Tang B, Iudicello JE, Ma Q, Franklin DR, Cookson D, et al. Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad558
BibTeX
@article{Trunfio2024,
author = {Trunfio, Mattia and Tang, Bin and Iudicello, Jennifer E and Ma, Qing and Franklin, Donald R and Cookson, Debra and Riggs, Patricia K and Cherner, Mariana and Moore, David J and Heaton, Robert K and Letendre, Scott L and Ellis, Ronald J},
title = {Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad558}
}
EUVIMED